№ files_lp_4_process_1_32040
File format: docx
Character count: 4708
File size: 29 KB
Year:
2023
Region / City:
Stillwater
Theme:
University Faculty Council Meeting
Document Type:
Meeting Agenda
Organization / Institution:
Oklahoma State University
Author:
Faculty Council
Target Audience:
Faculty, Staff, Students
Period of Validity:
August 15, 2023
Approval Date:
August 15, 2023
Date of Changes:
N/A
Context:
Document outlining the agenda and reports of various university councils and committees for the Faculty Council meeting at Oklahoma State University.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Organization:
Colorado Department of Transportation
Issuing Unit:
Construction Engineering Services Branch
Related Standard:
Standard Specifications for Road and Bridge Construction
Subject:
PCCP Acceptance and Recycled Concrete Aggregate
Referenced Sections:
105, 106, 412, 601
Applicable Item:
412 — Portland Cement Concrete Pavement
Applicable Projects:
CDOT construction projects with PCCP
Approval Authority:
CDOT Standards and Specifications Unit
Referenced Document:
Department’s Field Materials Manual
Referenced Standard:
AASHTO Standard Recommended Practice R-11
Payment Basis:
Incentive and Disincentive Payments (I/DP) based on Pay Factors (PF) and Quality Levels (QL)
Effective Use:
Mandatory as written without modification on specified projects
Year:
4 Semester: 2
Degree:
Bachelor of Laws
Date:
August 15, 2025
Note:
Year
2025
Region / City:
Kisii, Kenya
Theme:
Refugee and Immigration Law
Document Type:
University Examination
Institution:
Kisii University
Author:
Unknown
Target Audience:
University students, law professionals
Effective Period:
August 2025
Date of Approval:
N/A
Date of Revisions:
N/A
Year:
2023
Region / city:
Not specified
Theme:
Genetic Engineering, Bacterial Transformation, Protein Production
Document type:
Educational Material
Institution:
Not specified
Author:
Not specified
Target audience:
Students, educators, individuals interested in molecular biology
Period of validity:
Not applicable
Approval date:
Not specified
Modification date:
Not specified
Report Date:
03-Mar-2023
Aircraft Model:
Bell 412 HP
Serial Number:
33160
Manufacture Date:
1988
Registration:
P2-HCS
Total Hours:
9778.60
Total Cycles:
29142
Seating Capacity:
2+9
Next Inspection:
11-Apr-2023 / 13125.90 Hrs.
Engine Type:
PWC PT6T-3B
Engine Position LH Serial Number:
CP-PS62457
Engine Position LH TSN:
7570.10
Engine Position LH TSO:
2752.00
Engine Position RH Serial Number:
CPPS-TB0439
Engine Position RH TSN:
2985.60
Engine Position RH TSO:
New
Gearbox Serial Number:
CP-GB 1723
Gearbox TSN:
14544.30
Gearbox TSO:
372.00
Maximum Takeoff Weight:
11,900 LBS
Empty Weight:
7568 LBS
Avionics VHF Com:
Bendix/King KTR-908 (2 units)
Avionics HF Com:
Bendix/King KHF-950 (1 unit)
Avionics VHF FM Com:
TFM138B (1 unit)
Avionics Nav VOR/ILS:
Bendix/King KNR-634 (2 units)
Avionics ADF:
Bendix/King KDF-805 (1 unit)
Avionics Marker Receiver:
Bendix/King KMR-675 (1 unit)
Avionics DME:
Bendix/King KDM-706 (1 unit)
Avionics Radar Altimeter:
Bendix/King KRA-405B (1 unit)
Avionics ADS-B Transponder:
TT22 XPDR & TN70 GPS (1 unit)
Avionics Weather Radar:
Bendix/King RDR-2000 (1 unit)
Avionics ICS Audio Panel:
A301-6W (4 units)
Avionics ELT:
Artex C406-2 (1 unit)
Avionics GPS:
Garmin GPS-165 (2 units)
Note:
Avionics GPS
Garmin GPS-795 (1 unit)
Avionics Skynet:
S100 (1 unit)
Avionics Sat Phone:
Iridium 9505A (1 unit)
Mission Equipment:
Rescue Hoist Provision
Note:
Year
Topic:
Asphalt Mixture Design
Document Type:
Technical Specification
Target Audience:
Contractors, Engineers
Year:
2024
Region / City:
Washington, DC
Theme:
Postal Services / Competitive Products
Document Type:
Regulatory Order
Organization / Institution:
Postal Regulatory Commission
Author:
Postal Regulatory Commission
Target Audience:
Postal Service Stakeholders, Public Representatives, Competitive Product Stakeholders
Period of Action:
Effective immediately upon regulatory approval
Approval Date:
November 6, 2024
Modification Date:
None provided
Version:
Draft 2.0 | Effective: //_____ | Owner: Director of Special Education / 504 Coordinator | Approved by: __________________________
Year:
Draft 2.0
Region / City:
Midland ISD
Subject:
Special Education, Section 504
Document Type:
Manual
Organization / Institution:
Midland Independent School District
Author:
Director of Special Education
Target Audience:
School staff, administrators, special education professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual description:
A procedural manual for special education and Section 504 practices in Midland ISD, providing detailed operational steps for child find, referrals, evaluations, and compliance with federal and state regulations.
Year:
2026
Region / City:
European Union
Subject:
Pharmaceutical Product Information
Document Type:
Pharmaceutical Summary
Organization:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare professionals
Period of validity:
Ongoing
Approval Date:
2026
Date of Modifications:
2026
Contextual Description:
The document outlines the product characteristics, indications, dosage, administration guidelines, and precautions for the pharmaceutical product Tysabri, as approved by the European Medicines Agency.
Year:
2023
Region / city:
Australia
Topic:
Vedolizumab submission for chronic pouchitis treatment
Document type:
Submission for listing of medicinal product
Agency:
Therapeutic Goods Administration (TGA)
Author:
Takeda Pharmaceuticals Australia Pty. Ltd.
Target audience:
Healthcare professionals, regulatory authorities
Effective period:
From 29 June 2023
Approval date:
29 June 2023
Modification date:
N/A
Note:
Year
Organization / Institution:
National Oceanic and Atmospheric Administration (NOAA)
DUPILUMAB, 300 mg in 2 mL single use pre-filled syringe, Dupixent®, Sanofi-Aventis Australia Pty Ltd
Year:
2023
Region / City:
Australia
Subject:
Atopic dermatitis treatment
Document type:
Application resubmission
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Not specified
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2003
Region / City:
United States
Topic:
Insurance Verification, Billing Systems, Healthcare IT
Document Type:
Technical Manual / Security Guide
Organization:
Department of Veterans Affairs, Office of Information and Technology
Author:
MCCF EDI TAS eInsurance
Intended Audience:
Technical personnel for installation and maintenance of the software
Effective Period:
Ongoing updates
Approval Date:
September 2003
Revision Date:
August 2022
Year:
2026
Region / City:
Fort Collins, CO
Topic:
Parking System Consulting
Document Type:
Request for Quotation (RFQ)
Organization:
City of Fort Collins
Author:
Purchasing Division
Target Audience:
Professionals in the parking and urban planning sectors
Effective Period:
February 2026
Approval Date:
February 2026
Amendment Date:
Not specified
Type of document:
Pharmaceutical Benefits Advisory Committee (PBAC) submission and assessment report
Medicine:
Aripiprazole long-acting injectable (AOM)
Dosage forms/strengths:
Powder for injection 300 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe; Powder for injection 400 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe
Brand:
Abilify Maintena
Sponsor:
Lundbeck Australia Pty Ltd
Purpose of submission:
Request for General Schedule Authority Required (STREAMLINED) PBS listing of AOM pre-filled syringe dose form
Indication:
Treatment of schizophrenia
Comparator:
AOM modified release injection vial kit (therapeutic vial kits)
Regulatory status:
TGA registered 7 May 2018 for acute and maintenance treatment of schizophrenia in adults and maintenance treatment of bipolar I disorder (monotherapy)
Previous PBAC consideration:
400 mg AOM PFS recommended July 2018; recommendation rescinded March 2023
Pricing basis:
Cost-minimisation versus AOM vial kit with equivalent pricing (no price premium)
Price levels referenced:
DPMQ, PTP, AEMP (current as of 1 June 2025)
Estimated PBS usage:
400,000 to <500,000 scripts over first six years (Year 1 10,000–<20,000; Year 6 100,457)
Indication listing conditions:
Authority Required (Streamlined); prescriber types include medical practitioners and nurse practitioners; general schedule (Code GE)
Year:
2022
Region / City:
Australia
Subject:
Pharmacology, Pharmaceutical Benefits Scheme (PBS)
Document Type:
Submission
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Not specified
Approval Date:
3 June 2022
Date of Changes:
Not specified
Contextual Description:
A regulatory submission detailing the request for listing of dupilumab in new forms for treating severe atopic dermatitis and uncontrolled severe asthma in pediatric patients under the PBS.
Note:
Year
Agency / Institution:
Department of Professional and Financial Regulation, Bureau of Consumer Credit Protection
Note:
Year
Background:
The submission requested a General Schedule Authority Required (Telephone/Online) listing of a new form of adrenaline (epinephrine) acid tartrate 150 micrograms/0.15 mL autoinjector (AI) (Jext® Junior (Jr)) and 300 micrograms/0.3 mL AI (Jext®) under the same circumstances as the currently listed adrenaline (epinephrine) 150 microgram/0.3 mL AI (EpiPen® Jr and Anapen® Jr 150) and 300 microgram/0.3 mL AI (EpiPen® and Anapen® 300).
Year:
2021
Region / City:
Australia
Topic:
Atopic dermatitis treatment, medication submission
Document Type:
Submission report
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Sanofi-Aventis
Target Audience:
Medical professionals, regulatory authorities
Action Period:
Ongoing treatment evaluation
Approval Date:
17 August 2021
Modification Date:
Not specified
Background:
Dupilumab registration history
Clinical Claim:
Dupilumab has superior efficacy compared to standard care for children with severe atopic dermatitis
Episodicity:
Chronic
Severity:
Severe
Condition:
Atopic dermatitis
PBS Indication:
Chronic severe atopic dermatitis
Prescriber Type:
Medical practitioners, dermatologists, clinical immunologists
Treatment Phase:
Initial, continuing
Population Criteria:
Children aged 6 to 11 years, specific weight ranges
Comparator:
Placebo
Outcomes:
EASI-75, IGA 0 or 1 at Week 16, improvement in itch score
Dosing:
Tiered by body weight
Cost:
$1,754.28–$3,380.91
Price:
Published price for maximum quantity
Form:
Pre-filled syringe
Medical Information:
Dupilumab 300 mg/2 mL, 200 mg/1.14 mL
Note:
Comparator
Standard of care (Placebo)
Source:
PBAC submission